SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-010762
Filing Date
2019-06-14
Accepted
2019-06-14 16:08:59
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_inspyrtherape.htm 10-Q 779448
2 CERTIFICATION f10q0918ex31-1_inspyrther.htm EX-31.1 7522
3 CERTIFICATION f10q0918ex31-2_inspyrther.htm EX-31.2 7725
4 CERTIFICATION f10q0918ex32-1_inspyrther.htm EX-32.1 4858
5 CERTIFICATION f10q0918ex32-2_inspyrther.htm EX-32.2 5012
  Complete submission text file 0001213900-19-010762.txt   4278852

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20180930.xml EX-101.INS 742748
7 XBRL SCHEMA FILE nspx-20180930.xsd EX-101.SCH 47489
8 XBRL CALCULATION FILE nspx-20180930_cal.xml EX-101.CAL 47327
9 XBRL DEFINITION FILE nspx-20180930_def.xml EX-101.DEF 207666
10 XBRL LABEL FILE nspx-20180930_lab.xml EX-101.LAB 337782
11 XBRL PRESENTATION FILE nspx-20180930_pre.xml EX-101.PRE 298106
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 19898971
SIC: 2834 Pharmaceutical Preparations